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Abstract
Background:  Inflammation and nociceptive sensitization are hallmarks of tissue surrounding
surgical incisions. Recent studies demonstrate that several cytokines may participate in the
enhancement of nociception near these wounds. Since opioids like morphine interact with
neutrophils and other immunocytes, it is possible that morphine exerts some of its antinociceptive
action after surgical incision by altering the vigor of the inflammatory response. On the other hand,
keratinocytes also express opioid receptors and have the capacity to produce cytokines after
injury. Our studies were directed towards determining if opioids alter cytokine production near
incisions and to identify cell populations responsible for producing these cytokines.
Results:  A murine incisional model was used to measure the effects of acute morphine
administration (0.1–10 mg/kg) on nociceptive thresholds, neutrophil infiltration and cytokine
production in hind paw skin 30 minutes and 2 hours after incision. Incised hind paws displayed
profound allodynia which was reduced by morphine (0.1–10 mg/kg) in the 2 hours following
incision. Skin samples harvested from these mice showed enhanced levels of 5 cytokines: IL-1β, IL-
6, tumor necrosis factor alpha (TNFα), granulocyte colony stimulating factor (G-CSF) and
keratinocyte-derived cytokine (KC). Morphine reduced these incision-stimulated levels. Separate
analyses measuring myeloperoxidase (MPO) and using immunohistochemistry demonstrated that
morphine dose-dependently reduced the infiltration of neutrophils into the peri-incisional tissue.
The dose of morphine required for reduction of cytokine accumulation, however, was below that
required for inhibition of peri-incisional neutrophil infiltration. Additional immunohistochemical
studies revealed wound edge keratinocytes as being an important source of cytokines in the acute
phase after incision.
Conclusion: Acute morphine administration of doses as low as 0.1 mg/kg reduces peri-incisional
cytokine expression. A reduction in neutrophil infiltration does not provide a complete explanation
for this effect, and keratinocytes may be responsible for some incision area cytokine production.
These studies suggest that morphine may alter the inflammatory milieu of incisional wounds, but
these alterations do not likely contribute significantly to analgesia in the acute setting.
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Background
Surgically incised tissue provides an archetypical example
of acute inflammation in which all classical signs and
symptoms can be present: redness, swelling, heat, pain
and reduced function. Investigators representing many
disciplines have studied the mechanisms supporting
inflammation in surgical wounds, and much has been
learned about healing, infection and, more recently, pain
related to wound inflammation. In fact, cytokines have
long been recognized as controlling wound healing and
resistance to wound infection [1,2]. It has been only
recently, however, that we have recognized that cytokines
produced in wounds or in peripheral neurons serving
wounded tissues might influence pain and be legitimate
targets for analgesic development. For example, the skin
surrounding incisions and excisional biopsy sites has
been shown to contain elevated amounts of several
cytokines including interleukin-1β (IL-1β), interleukin-6
(IL-6), tumor necrosis factor-α (TNFα) and others [3,4].
Each of these cytokines has been observed to support
enhanced nociceptive sensitivity in various rodent models
[5-7]. Other cytokines such as IL-12 and IL-18 have also
been shown to support nociception [8,9], though a few
cytokines such as IL-4, IL-10 and IL-13 have anti-nocicep-
tive effects [10]. The effects of cytokines may be model-
specific, however. For example, a TNF receptor IgG fusion
protein had no effect on incision-induced pain-related
behaviors [11].
A recent report provided a somewhat more comprehen-
sive profile of the types of cytokines expressed in response
to skin incision, and the time course of those changes rel-
ative to nociceptive sensitization of the incised mouse
hind paws [12]. This study identified enhanced levels of
IL-1β, IL-6 and TNFα consistent with previous observa-
tions, but also suggested that granulocyte colony stimulat-
ing factor (G-CSF) and keratinocyte-derived cytokine
(KC) were present in enhanced levels after incision. How-
ever, we have a poor overall understanding at this time of
the relationship between this growing list of cytokines
and incisional pain. Highlighting the difficulties in under-
standing the roles of cytokines in pain are observations
that cytokines like IL-1β may have demonstrable roles in
models of neuropathic and some types of inflammatory
pain but not after incision [13]. A recent review discusses
the complexity of cytokine biology as it relates to nocice-
ption [14].
Though largely unexplored, the presence of opioid recep-
tors in skin and inflammation-related immunocytes sug-
gests the possibility that acute or chronically administered
opioids modulate incisional cytokine levels thereby influ-
encing pain, swelling and other aspects of acute inflam-
mation. Acutely administered opioids can, in fact, modify
the degree of swelling caused by intradermal carrageenan
injection [15,16]. Furthermore, opioid receptors are
expressed by keratinocytes, the cells responsible for most
skin cytokine production under resting conditions [17],
and neutrophils which are acute phase immunocytes
found in surgical wounds [18,19]. Reports over the past
20 years have described effects of endogenous and exoge-
nous opioids in modulating both neutrophil migration
and function [20-25] though these effects have not been
studied in surgical wounds or with respect to pain. The
principal goals of this study were, therefore, to determine
if opioids like morphine could modulate wound cytokine
levels when administered acutely, and whether any differ-
ences in cytokine levels identified might be attributable to
opioid effects on wound area neutrophil infiltration ver-
sus enhanced production by resident cells.
Results
Acute morphine administration reduces mechanical 
allodynia after hind paw incision
Prior to investigating the effects of morphine on inci-
sional cytokines, it was necessary that we establish dose-
dependent effects of morphine on nociceptive sensitiza-
tion resulting from incision. We therefore measured
mechanical nociceptive thresholds before, 30 minutes
and 2 hours after hind paw incision. Mice used in these
experiments were given various doses of subcutaneous
morphine taken from the C57BL/6 analgesia concentra-
tion range as established in other models [26,27]. We
have previously established the duration of analgesia of
the highest morphine dose given (10 mg/kg) to be
approximately 2 hours, and that the analgesic effects are
maximal within 30 minutes of administration [26]. The
lower morphine doses used in these studies overlap the
dose range employed clinically for the management of
perioperative pain. As shown in Figure 1, morphine given
prior to incision dose-dependently reduced mechanical
allodynia for up to 2 hours after incision. The lowest dose
of morphine used failed to reverse mechanical sensitiza-
tion 30 minutes after hind paw incision. All doses of mor-
phine provided a modest anti-allodynic effect 2 hours
after incision.
Acute morphine administration reduces peri-incisional 
cytokine production after hind paw incision
In order to examine the possible immunomodulatory
activity of morphine, we selected cytokines known to be
present in increased amounts after hind paw incisions in
mice based on our previous studies [12]. Thus the levels
of IL-1β, IL-6, tumor necrosis factor alpha (TNFα), granu-
locyte colony stimulating factor (G-CSF) and keratinoc-
yte-derived cytokine (KC) were followed. Measurements
made at the 30 minute time point revealed that no eleva-
tions in wound area cytokine levels were yet measurable
(data not shown). However, the data presented in Figure
2 show that the levels of the selected cytokines increasedMolecular Pain 2007, 3:28 http://www.molecularpain.com/content/3/1/28
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from 1.8 (TNFα) to >15-fold (G-CSF, KC) at 2 hours post
incision. Other groups of animals were given morphine at
either the highest dose used in the behavioral studies (10
mg/kg), or the lowest dose (0.1 mg/kg). Neither dose of
morphine affected cytokine levels at 30 minutes after inci-
sion. On the other hand, at 2 hours morphine adminis-
tered prior to incision strongly reduced cytokine levels at
one or both of the doses tested. For the majority of
cytokines the lower 0.1 mg/kg morphine dose had signif-
icant effects. The chemotactic cytokine KC, however,
showed the same degree of induction after the injection of
0.1 mg/kg morphine as when saline was administered.
Acute morphine administration reduces peri-incisional 
neutrophil infiltration after hind paw incision 
(myeloperoxidase assay, MPO)
Because of the large reductions in incised skin cytokine
levels caused by acute morphine administration we pro-
ceeded to examine the infiltration of neutrophils, a poten-
tial source of wound cytokines. Wound skin edge
neutrophil infiltration was assessed using a biochemical
assay for myeloperoxidase (MPO) activity as has been
employed for skin samples taken from excisional biopsy
sites, scald wounds and after irritant injection [15,28,29].
In Figure 3 data are displayed demonstrating that even at
30 minutes after incision, MPO activity was measurably
increased from baseline, and that 10 mg/kg but not 0.1
mg/kg morphine injection prior to incision strongly
reduced the MPO activity at both time points.
Acute morphine administration reduces peri-incisional 
neutrophil infiltration after hind paw incision 
(Immunohistochemistry)
In Figure 4 we present micrographs of wound edge tissue
taken both before and 2 hours after incision. These were
stained with either H&E or a neutrophil specific antibody.
Examination of sections from incised versus control ani-
mals revealed the presence of a dense neutrophil infiltra-
tion after incision. Quantification of neutrophils in the
wound edges revealed an approximate 40% reduction in
neutrophil counts in the 10 mg/kg morphine treated ani-
mals at both 30 minutes and 2 hours when compared
with samples from saline vehicle treated mice while (Fig-
ure 5). Consistent with the MPO data, 0.1 mg/kg had no
significant effect.
Incision leads to cytokine expression in the epidermis as 
well as in infiltrating neutrophils
Because of the discordance in morphine effects on reduc-
ing wound edge cytokine levels versus effects on neu-
trophil infiltration, we attempted to identify additional
cell types near the incisions producing cytokines. For
these studies we chose to stain skin for an interleukin
showing a large changes in expression after incision (IL-
1β), G-CSF as it is proposed to have a role in supporting
Morphine effects on post-incisional allodynia in mice Figure 1
Morphine effects on post-incisional allodynia in mice. In these 
experiments the mechanical withdrawal thresholds of mice 
were measured before and at two time points after hind paw 
incision. Mice received saline or various doses of morphine 
immediately prior to making the incisions. Panel A displays 
the time course data. Panel B presents the mechanical 
thresholds for each group as a percent of the threshold for 
saline treated animals 30 minutes after incision. Panel C 
presents the mechanical thresholds for each group as a per-
cent of the threshold for saline treated animals 2 hours after 
incision. Each group contained 5 mice. **p < 0.01 relative to 
saline treated animals.Molecular Pain 2007, 3:28 http://www.molecularpain.com/content/3/1/28
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Hind paw skin cytokine levels at baseline and 2 hours after incision Figure 2
Hind paw skin cytokine levels at baseline and 2 hours after incision. For these experiments skin was harvested at baseline and 
2 hours after incision near the end of the measured morphine analgesic effects. Mice were given saline or morphine of various 
doses immediately prior to the incisions being made. These analyses used tissue from 6 mice per treatment condition. The sta-
tistical significance of incised skin versus incised with prior morphine treatment was assessed. **p < 0.01.Molecular Pain 2007, 3:28 http://www.molecularpain.com/content/3/1/28
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anti-inflammatory processes in the innate and adaptive
immune systems [30], and KC since its sensitivity to mor-
phine was distinct from the other 4 cytokines studied. In
each case we identified strong expression of these
cytokines in the keratinocytes comprising the epithelium
of the skin adjacent to the 2 hour old incisional wounds
(Figure 6). Also evident in Figure 6 are infiltrating immu-
nocytes in dermal tissue expressing each of these
cytokines. Double staining experiments established these
to be neutrophils. Figure 7 demonstrates dermal peri-inci-
sional neutrophils expressing IL-1β. Images from other
double labeling experiments involving anti-neutrophil
along with anti-G-CSF and anti-KC antibodies were simi-
lar in that neutrophils were observed to express each of
these cytokines as well (data not shown).
Discussion
In these investigations we set out to determine whether
morphine administered acutely would alter skin incision
cytokine levels, neutrophil infiltration or the nociceptive
sensitization which accompanies this type of tissue
trauma. The generation of cytokines after incision has
importance in several areas including the maintenance of
pain, combating infection and controlling wound heal-
ing. Factors significantly affecting cytokine production
may, therefore, impact several processes important in the
perioperative period. Consistent with our hypothesis, the
acute pre-incisional administration of morphine reduced
wound area cytokine production. Given the large effects
on cytokine production, we went on to determine if mor-
phine was reducing neutrophil migration to the wound
area. Both a biochemical assay involving the quantifica-
tion of myeloperoxidase (MPO) and immunohistochem-
ical examination showed morphine mediated reductions
in wound area neutrophil presence 30 minutes and 2
hours after hind paw incisions when a morphine dose of
10 mg/kg was administered. However, with the exception
of KC levels, peri-incisional cytokine levels were reduced
Peri-incisional infiltration of neutrophils, immunohistochemical appearance Figure 4
Peri-incisional infiltration of neutrophils, immunohistochemical appearance. Hind paw skin from incised mice was processed for 
the identification of neutrophils. Panel A displays an H&E stained section of plantar hind paw skin demonstrating a predomi-
nantly dermal cellular infiltrate 2 hours after incision. The dermal and epidermal layers are labeled. Panel B displays the appear-
ance of non-incised hind paw skin stained with a neutrophil-specific antibody. Panel C displays a micrograph taken of incised 
skin stained for neutrophils 2 hours after incision. Note the abundance of darkly staining infiltrating neutrophils in the dermis of 
this section compared to that displayed in panel B. The scale bar in panel C is 150 µm in length. All micrographs were taken 
using 200× magnification.
Myeloperoxidase levels in skin before and after hind paw inci- sion Figure 3
Myeloperoxidase levels in skin before and after hind paw inci-
sion. The skin of mouse hind paws was harvested before, 30 
minutes after incision or 2 hours after incision. Incised ani-
mals were given saline or morphine of the indicated doses 
prior to incision. Eight control or incised samples per condi-
tion were used. Statistical analysis reflects differences in 
MPO levels versus control pre-incision levels. **p < 0.01.Molecular Pain 2007, 3:28 http://www.molecularpain.com/content/3/1/28
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by the 100-fold lower 0.1 mg/kg morphine dose, a dose at
which neutrophil infiltration was unaffected. Therefore,
the morphine-induced reductions in cytokine levels can-
not be due to reduced neutrophil infiltration alone. In
fact, there appears to be a significant temporal delay
between the arrival of neurtrophils in the wound and the
production of cytokines (Figures 2 and 3). Keratinocytes
were identified as an alternative source of peri-incisional
cytokines.
Ours are not the first data supporting the notion that an
acutely administered exogenous opioid can reduce
inflammation and the abundance of key inflammatory
mediators. Fecho et al. reported recently that the hind paw
swelling induced by carrageenan injection could be
reduced by morphine, and that MPO levels could be low-
ered by this opioid as well [15]. Systemic TNFα and IL-6
levels were not found to be changed in these experiments
though local skin levels were not assessed. Similar studies
were undertaken by Pourpak et al. who reported that high
(7 mg/kg) but not low (1 mg/kg) doses of systemic mor-
phine reduced hind paw swelling after carrageenan injec-
tion. In this study, however, the high dose of morphine in
combination with carrageenan actually increased serum
IL-1β levels [16]. Our results are somewhat different in
that morphine consistently reduced local tissue inter-
leukin levels and nociceptive sensitization across a wide
dose range. One explanation for the differences in the
reported results could be that we measured cytokine levels
at the actual site of tissue trauma. These levels may be
driven by factors partially separate from those controlling
systemic levels.
Aside from the pain related studies, the influences opioids
have on neutrophil function have long been of interest
particularly as the findings might help us to understand
possible differences in the risk of infection amongst drug
abusers, burn victims and postoperative patients. One of
the earliest studies conducted in the perioperative setting
showed that relatively large (for humans) doses of mor-
phine (0.5–1.1 mg/kg) inhibited neutrophil chemotaxis
[24]. Our MPO data from mice having received the larger
10 mg/kg morphine dose prior to incision are consistent
with these observations. Later studies confirmed these
findings and showed definitively that both µ- and δ-opi-
oid receptors likely mediate these opioid effects [20,22]. A
larger field of work suggests that morphine and other opi-
oids alter various aspects of immune system functioning
including infection fighting, tumor cell destruction, lym-
phocyte proliferation, and apoptosis [31-33]. Impor-
tantly, morphine has been demonstrated to reduce
neutrophil phagocytic activity [20,25,34-36]. Thus mor-
phine may affect neutrophil function in many ways other
than wound area infiltration as followed in our experi-
ments. For example, morphine may reduce cytokine pro-
duction in neutrophils infiltrating peri-incisional skin
though we have not yet tested this hypothesis.
While the focus of most work concerning opioid effects in
wounds has centered on neutrophils and other immuno-
cytes, resident cells such as keratinocytes also express
functional µ-opioid receptors [17,37]. The keratinocytes
of the epidermis also produce endogenous opioid pep-
tides, though little study has been devoted to the ability of
these peptides to alter skin cytokine levels [17,38].
Because low dose (0.1 mg/kg) morphine strongly reduced
incision-induced cytokine level increases for most of the
measured cytokines but failed to reduce neutrophil infil-
tration at this dose, we considered other cell types as
sources of wound cytokines. The results shown in Figure 6
demonstrate that cytokine production is strongly up-regu-
lated within 2 hours of incision in the epidermis. Within
the epidermis, it is primarily the basal and suprabasal
layer keratinocytes which express µ-opioid receptors
[37,39,40]. These receptors have been linked with control
of cell migration in cultures of keratinocytes [41]. Further-
more, keratinocytes have been demonstrated to be impor-
tant sources of skin cytokines in other models. For
example, keratinocytes appeared to be an important
source of IL-10 in a separate murine incisional wound
model [42]. Also, keratinocytes stimulated with the noci-
ception related peptides substance P (SP) and calcitonin
gene related peptide (CGRP) express enhanced levels of
IL-1α, IL-8 and TNFα [43]. It is possible, therefore, that
morphine controls skin cytokine levels by virtue of a
Peri-incisional infiltration of neutrophils, immunohistochemi- cal quantification Figure 5
Peri-incisional infiltration of neutrophils, immunohistochemi-
cal quantification. The number of neutrophils in 0.01 mm2 un-
incised plantar skin or skin adjacent to incisions is presented. 
Animals were injected with saline or morphine 0.1 or 10 mg/
kg prior to incision as indicated. For each condition 3–5 sec-
tions from 4 control or incised paws were analyzed. Statisti-
cal analysis was performed to detect differences between 
saline treated and morphine treated neutrophil counts. **p < 
0.01.Molecular Pain 2007, 3:28 http://www.molecularpain.com/content/3/1/28
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direct interaction with keratinocytes or by reducing the
release of substance P and CGRP from cutaneous nocice-
ptors, which, in turn, reduces the production of cytokines
by resident skin cells. Further experiments performed in
well-defined cell culture systems may tell us whether
endogenous or exogenous opioids alter keratinocyte
cytokine production.
Interestingly, the one cytokine measured not displaying
decreased abundance in the incised skin of mice after low
dose (0.1 mg/kg) morphine administration was KC. This
low morphine dose also did not reduce neutrophil infil-
tration. This cytokine has powerful neutrophil chemoat-
tractant properties in mouse skin, and is thought to be
responsible for much of the early neutrophil infiltration
in surgical and scalded skin injury models [44,45].
Though we did not specifically investigate the hypothesis,
it appears possible that production of this cytokine is
under separate control from the other incision related
cytokines and is one of the factors responsible for the
recruitment of neutrophils into hind paw incisional
wounds. With respect to nociception, however, other
investigators have demonstrated that KC induced neu-
trophil infiltration by itself is not sufficient to cause ther-
mal or mechanical hyperalgesia in rodent hind paw tissue
[46].
Confocal micrographs of incised skin Figure 6
Confocal micrographs of incised skin. For these studies skin from the wound edges was collected 2 hours after the incisions 
were made. The tissue was sectioned and exposed to antibodies for IL-1β, G-CSF or KC then CY3 conjugated antibody allow-
ing detection by fluorescence. Some sections were processed without primary antibody as controls (labeled "C"). These micro-
graphs were taken under 400× magnification. The scale bar in the lower right hand (KC) panel is 100 µm in length.Molecular Pain 2007, 3:28 http://www.molecularpain.com/content/3/1/28
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Our data also allow us to comment on the likely impor-
tance of the group of cytokines we studied to allodynia
after incision. First, at 30 minutes after incision allodynia
was maximal yet cytokine levels had not yet changed. Fur-
thermore, Figure 1 demonstrates that at the 2 hour time
point mechanical thresholds are reversed only to about
40% of baseline with 10 mg/kg morphine and are
reversed to an even lesser extent by 0.1 mg/kg morphine
despite skin cytokine levels being at essentially baseline
levels (Figures 1, 2). Thus it seems very likely that factors
other than cytokines are strong contributors to allodynia
after incision at these acute time points. Some locally pro-
duced factors which are more likely to contribute to acute
incisional wound nociceptive sensitization include hydro-
gen ion, ATP, neuropeptides, prostaglandins, bradykinin,
serotonin and other molecules. By extension, it appears
unlikely that analgesic therapies directed only at reducing
wound levels of the cytokines we studied would have a
high degree of efficacy within the first few hours after inci-
sion. As mentioned in the introduction, the roles of TNFα
and IL-1β in supporting mechanical sensitization after
incision have been questioned [11,13]. It needs to be rec-
ognized, however, that we measured only mechanical
thresholds, and that the cytokines studied might be
involved to a greater extent in controlling thermal or other
types of nociceptive sensitization. This seems to be the
case for NGF which supports thermal to a greater extent
than mechanical sensitization in tissue surrounding inci-
sions [11].
Rather than considering incisional wounds as static
lesions, we may need to consider the possibility that the
wound area mechanisms supporting nociception change
rapidly over the fist few hours to days and that the phar-
macology of nociception may change over this time
course as well. In this regard it is notable that a comple-
ment fragment C5a antagonist was more effective at
reversing wound area mechanical allodynia 24 hours after
incision when the levels of several C5a-regulated
cytokines were at maximum than 2 hours after incision
[12]. In the present study the 0.1 mg/kg dose of morphine
had no effect at 30 minutes but did modestly reverse allo-
dynia at the 2 hour time point where the same dose
strongly reduced wound area cytokines. Cytokine partici-
pation in supporting nociception may be very different at
24 hours following incision. Our data are also consistent
with the hypothesis that it takes hours for cytokines to
accumulate in wounds to the point where they are impor-
tant contributors to nociceptive sensitization. Additional
experiments employing selective opioid receptor antago-
nists, cytokine neutralizing antibodies and mediator
knockout mice at a wider range of time points will be nec-
essary to fully define the role of cytokines in post-inci-
sional nociceptive sensitization.
Conclusion
We currently focus on the direct neuromodulatory effects
of opioids to explain the analgesic effects of these drugs
after surgery. Indeed there are substantial data supporting
both central and peripheral neuronally mediated opioid
analgesic effects. It is also true that a growing body of lit-
erature supports pro-nociceptive functions for a range of
cytokines. In these studies we were able to show that while
morphine can reduce these wound area cytokines, such
Confocal neutrophil-cytokine double labeling experiments using incised skin Figure 7
Confocal neutrophil-cytokine double labeling experiments using incised skin. For these studies skin from the wound edges was 
harvested 2 hours after incision. After sectioning, the tissue was exposed to anti-neutrophil and anti-IL-1β antibodies followed 
by the application of CY3 (green fluorescence, neutrophils, panel A) and FITC (red, IL-1β, panel B) conjugated secondary anti-
bodies. Panel C presents the merged image with arrows pointing to several strongly double labeling cells. The scale bar in panel 
C is 50 µm in length. These micrographs were taken of dermal tissue under 630× magnification.Molecular Pain 2007, 3:28 http://www.molecularpain.com/content/3/1/28
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reductions contribute only minimally to anti-nociception
in the acute setting. Aside from potentially affecting noci-
ception, the inflammation altering effects of exogenous
opioids may affect resistance to infection and perhaps the
healing characteristics of these wounds. Future studies
might be directed at addressing all three of these possibil-
ities across a broader time course after surgical incision.
Methods
Animal use
All experimental protocols were reviewed and approved
by Veterans Affairs Palo Alto Healthcare System institu-
tional animal care and use committee prior to the initia-
tion of work. Male mice 12–14 weeks old of the C57Bl/6J
strain were kept under standard conditions with a 12 h
light/dark cycle and allowed food and water ad libitum.
Mice were obtained from Jackson Laboratories (Bar Har-
bor, MA) and were kept in our animal facility a minimum
of 1 week prior to use in experiments.
Hind paw incision
The hind paw incision model was used as modified for
mice [47]. We have used this model previously in order to
study cytokine levels following incision [12]. Briefly, mice
were anesthetized using isoflurane. After sterile prepara-
tion, a 0.5 cm incision was made with a #15 scalpel blade
on the plantar surface of one hind paw. This incision was
sufficiently deep to divide the plantaris muscle longitudi-
nally. After briefly holding pressure to stop any active
bleeding, a single 6-0 nylon suture was placed and antibi-
otic ointment applied. Mice were then returned to their
cages on soft bedding. Nociceptive testing and tissue har-
vest took place 30 minutes or 2 hours after incision.
Drug administration
Morphine or saline vehicle was administered immediately
prior to incision. To accomplish this, 100 µl 0.9% NaCl
with or without morphine (0.1–10 mg/kg, Sigma Chemi-
cal, St. Louis, MO) was injected subcutaneously into the
skin of the back.
Nociceptive testing
Mechanical allodynia was assayed using nylon von Frey
filaments according to the "up-down" algorithm
described by Chaplan et al. [48] as we have used previ-
ously to detect allodynia in mice [12,49,50]. In these
experiments mice were placed on wire mesh platforms in
clear cylindrical plastic enclosures 10 cm in diameter.
After 15 minutes of acclimation, fibers of sequentially
increasing stiffness were applied 1 mm lateral to the
wound edge, pressed upward to cause a slight bend in the
fiber and left in place 5 sec. Withdrawal of the hind paw
from the fiber was scored as a response. When no
response was obtained the next stiffest fiber in the series
was applied to the same paw; if a response was obtained a
less stiff fiber was applied. Testing proceeded in this man-
ner until 4 fibers had been applied after the first one caus-
ing a withdrawal response allowing the estimation of the
mechanical withdrawal threshold [51].
Cytokine analysis
To obtain skin samples for cytokine quantification ani-
mals were first sacrificed by CO2 asphyxiation and an
ovular patch of full-thickness skin providing 1.5 mm mar-
gins surrounding the hind paw incisions was collected by
dissection. Each such patch contained approximately 12
mg tissue. These samples were placed immediately into
ice cold 0.9% NaCl containing a cocktail of protease
inhibitors (Complete™, Roche Applied Science, Indianap-
olis, IN). Approximately 750 µl inhibitor containing
saline was used per 25 mg tissue. The samples were
homogenized using a Polytron device (Brinkman Instru-
ments Inc., Westbury, NY), then centrifuged for 10 min at
12,000 times gravity at 4°C. Supernatant fractions were
kept frozen at -80°C until use. An aliquot was subjected
to protein assay (DC Protein Assay, Bio-Rad Laboratories,
Hercules, CA).
For the cytokine assays, custom Bio-Rad (Bio-Rad labora-
tories, Hercules, CA) Bio-Plex cytokine analysis kits were
used in conjunction with the Bio-Plex system array reader
according to the manufacturer's directions as described
previously [12]. The specific cytokines were chosen based
on our previously reported results. Samples were diluted
1:2 prior to analysis, and all samples were run in duplicate
in each assay. We demonstrated previously that the
dynamic range of sensitivity of this assay was sufficient to
accurately measure both basal and incision-stimulated
levels of the chosen cytokines [12]. Standard curves for
each of the analyzed substances were included in each
run, and sample concentrations were calculated using Bio-
Plex Manager software.
Histological analysis
We have previously reported our methods for the immu-
nohistochemical analysis of incised mouse paw skin [12].
For these analyses mice were sacrificed using carbon diox-
ide asphyxiation which was followed by intracardiac per-
fusion of 20cc 0.9% NaCl followed by 20 ml of 10%
neutrally buffered formalin. Hind paws were then
removed and incubated in 10% buffered formalin for 24
hours. After overnight decalcification, tissue was proc-
essed for paraffin sectioning in automated fashion (Tissue
Tek VIP, Miles Scientific, Naperville, IL). Following
embedding, 6.5 µM slices were made, placed on slides and
incubated for 20 min at 55°C to improve adherence.
Some sections were stained with hematoxylin and eosin
(H&E). These were viewed and imaged using an Olympus
BH-2 microscope and Spot RT digital imaging equipment
(Diagnostic Instruments, Sterling Heights, MI).Molecular Pain 2007, 3:28 http://www.molecularpain.com/content/3/1/28
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Other paraffin sections were processed for the identifica-
tion of neutrophils. Paraffin was removed with graded
xylenes then re-hydrated in ethanol. Endogenous peroxi-
dase was quenched by incubation in 0.3% H2O2 for 30
minutes. Blocking of these sections took place for 3 hours
in 5% normal rabbit serum followed by exposure to rat
anti-mouse neutrophil antibody 1:5000 (MCA7771GA,
Serotec, Raleigh, NC). After additional rinsing, ABC rea-
gents were applied according to the manufacturers direc-
tions (Vector labs, Burlingame, CA) followed by the
application of coverslips using Permount (Biomedia, Fos-
ter City, CA). Control experiments included incubation of
slices in primary or secondary antibody-free solutions
both of which resulted in low intensity non-specific stain-
ing patterns in preliminary experiments. The specificity of
the anti-neutrophil antibody was confirmed by Western
blotting.
The quantification of neutrophils was done with the
counter blind to the treatment condition. After collecting
images using 100–400× total magnification, the number
of neutrophils in a rectangle with boundaries from the
skin surface to a point 200 µm deep and from the lateral
wound edge inward 50 µm were counted.
Additional experiments involved confocal imaging. For
these studies blocking of paraffin sections took place over-
night at 4°C in tris buffered saline (TBS) containing 5%
dry milk, followed by exposure to one of the following
primary antibodies overnight at 4°C in milk-TBS: polyclo-
nal anti-IL1β, 1:500 (Santa Cruz Biotechnology, Santa
Cruz, CA); polyclonal anti-G-CSF, 1:200 (Abcam Inc.);
polyclonal anti-KC/GROα, 1:50 (Santa Cruz). Sections
were also exposed to anti-mouse neutrophil antibody
1:5000 (Serotec). Sections were then be rinsed and trans-
ferred to milk-TBS containing fluorescein conjugated sec-
ondary antibodies 1:300–1:500 (Jackson
ImmunoResearch Laboratories, West Grove, PA) and
incubated for another 1 hour. After washing, coverslips
were applied. Confocal laser-scanning microscopy was
carried out using a Zeiss LSM/510 META microscope.
Images were stored on digital media. Control experiments
included incubation of slices in primary and secondary
antibody-free solutions both of which lead to low inten-
sity non-specific staining patterns in preliminary experi-
ments.
Myeloperoxidase (MPO) assay
MPO activity was measured as a biochemical index of
neutrophil recruitment in the wound edge samples [52].
Excised skin samples were washed in PBS and homoge-
nized in 1 ml 50 mM potassium phosphate-buffer solu-
tion with 0.5% hexadecyl trimethyl ammonium bromide
(Sigma Chemical Co., St. Louis, MO) and 5 mM EDTA.
The samples were then homogenized as above and centri-
fuged at 12,000 rpm at 4°C. MPO activities in the super-
natants were then assayed using a peroxidase assay kit
(Anaspec, San Jose, CA) along with supplied standards
according to the manufacturer's instructions. The data
were expressed as MPO activity in mU per mg protein in
the supernatant samples.
Statistical analysis
Analysis of repeated parametric measures was accom-
plished using a one-way ANOVA analysis of variance fol-
lowed by post-hoc Dunnett's testing or a two-way ANOVA
followed by Bonferroni testing. For simple comparisons
of 2 means t-testing was employed. A value of p < 0.05 was
taken to be significant. All data are presented as means +/
- S.E.M. unless otherwise noted.
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